PEACe: Ivy, Thyme and Cisti Extract (Phytus) Efficacy in Acute Cough (PEACe)
Primary Purpose
Cough, Common Cold
Status
Completed
Phase
Phase 4
Locations
Pakistan
Study Type
Interventional
Intervention
Phytus (Cisti, Thyme and Ivy Leaves)
Sponsored by
About this trial
This is an interventional treatment trial for Cough focused on measuring cough, thyme, Cisti, Ivy Leaves
Eligibility Criteria
Inclusion Criteria:
- Cough attributed to URTI such as the common cold
- Moderate to severe day cough according to questionnaire (score at least 3 on all 3 questions relating to day cough) considering the day prior to enrollment.
- Moderate to severe night cough score according to questionnaire (score at least 3 of 2 of the three questions relating to the evaluation of nocturnal cough
Exclusion Criteria:
- Diagnosis of chronic cardiac condition, or cystic fibrosis or any anatomical respiratory tract anomalies,
- Received antihistamines or any cough medicine the day prior to study entry,Known sensitivity to any component of Phytus
Sites / Locations
- KCHS Medical Center 1st Floor, Tipu Sultan Road.
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Intervention
Arm Description
Phytus (Cisti, thyme and Ivy leaves) given to patients on day 1 and day 4. On 4th day, night and day cough score along with adverse event will be assessed. Sponsor will bear the treatment cost during the study time period.
Outcomes
Primary Outcome Measures
Change in day cough score at end of study
A validated cough questionnaire measuring 3 aspects of daytime cough (frequency, severity, bothersomeness) on a 7 point Likert scale was used each evening to rate the passed day, as regards these aspects. The scale rates each parameter from 0 (not at all) to 6 (extremely)
Secondary Outcome Measures
Change in night cough score at end of study
A validated cough questionnaire measuring 5 aspects of night cough (frequency, severity, bothersomeness, child sleep and parents' sleep) on a 7 point Likert scale was used each morning to rate the past night. The scale rates each parameter from 0 (not at all) to 6 (extremely).
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02981147
Brief Title
PEACe: Ivy, Thyme and Cisti Extract (Phytus) Efficacy in Acute Cough
Acronym
PEACe
Official Title
PEACe: Ivy, Thyme and Cisti Extract (Phytus) Efficacy in Acute Cough
Study Type
Interventional
2. Study Status
Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
March 14, 2017 (Actual)
Primary Completion Date
December 30, 2017 (Actual)
Study Completion Date
March 30, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
PharmEvo Pvt Ltd
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to investigate the efficacy of Phytus in Acute Cough
Detailed Description
Common colds are the most frequently encountered human diseases worldwide. Common cold is a conventional term used for mild upper respiratory illnesses, which comprises a heterogeneous group of self-limited diseases caused by numerous viruses. The frequency is age-specific with fewer episodes in adults than in younger children. Cough due to the common cold is probably the most common cause of acute cough. In a significant subset of patients with "post infectious" cough, the etiology is probably an inflammatory response triggered by a viral upper respiratory infection (ie, the common cold). The resultant sub-acute or chronic cough can be considered to be due to an upper airway cough syndrome, previously referred to as postnasal drip syndrome.
Thyme leaf (Thymus vulgaris) expels phlegm and relieves congestion . It is antiseptic and an immune stimulant. The primary chemical constituents of Thyme include essential oil (borneol, carvacrol, cymol, linalool, thymol), bitter principle, tannin, flavonoids (apigenin, luteolin), saponins, and triterpenic acids. Thyme warms and stimulates the lungs, expels mucus, and relieves congestion. It also helps deter bacterial, fungal, and viral infections. The thymol content of thyme works as an expectorant and cough suppressant and is frequently used in cough syrups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cough, Common Cold
Keywords
cough, thyme, Cisti, Ivy Leaves
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
210 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Phytus (Cisti, thyme and Ivy leaves) given to patients on day 1 and day 4. On 4th day, night and day cough score along with adverse event will be assessed. Sponsor will bear the treatment cost during the study time period.
Intervention Type
Drug
Intervention Name(s)
Phytus (Cisti, Thyme and Ivy Leaves)
Other Intervention Name(s)
herbal medicine
Intervention Description
Phytus is a medicinal herb containing Ivy leaves, Cisti and Thyme.
Primary Outcome Measure Information:
Title
Change in day cough score at end of study
Description
A validated cough questionnaire measuring 3 aspects of daytime cough (frequency, severity, bothersomeness) on a 7 point Likert scale was used each evening to rate the passed day, as regards these aspects. The scale rates each parameter from 0 (not at all) to 6 (extremely)
Time Frame
4 nights (onset of trial Night 1 to Night 4)
Secondary Outcome Measure Information:
Title
Change in night cough score at end of study
Description
A validated cough questionnaire measuring 5 aspects of night cough (frequency, severity, bothersomeness, child sleep and parents' sleep) on a 7 point Likert scale was used each morning to rate the past night. The scale rates each parameter from 0 (not at all) to 6 (extremely).
Time Frame
4 nights (onset of trial Night 1 to Night 4)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Cough attributed to URTI such as the common cold
Moderate to severe day cough according to questionnaire (score at least 3 on all 3 questions relating to day cough) considering the day prior to enrollment.
Moderate to severe night cough score according to questionnaire (score at least 3 of 2 of the three questions relating to the evaluation of nocturnal cough
Exclusion Criteria:
Diagnosis of chronic cardiac condition, or cystic fibrosis or any anatomical respiratory tract anomalies,
Received antihistamines or any cough medicine the day prior to study entry,Known sensitivity to any component of Phytus
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Masood Jawaid, MRCS,FCPS
Organizational Affiliation
PharmEvo Pvt Ltd
Official's Role
Study Director
Facility Information:
Facility Name
KCHS Medical Center 1st Floor, Tipu Sultan Road.
City
Karachi
State/Province
Sindh
Country
Pakistan
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
PEACe: Ivy, Thyme and Cisti Extract (Phytus) Efficacy in Acute Cough
We'll reach out to this number within 24 hrs